{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-013244","form_type":"8-K","ticker":"PMN","cik":"0001374339","company_name":"ProMIS Neurosciences Inc.","filed_at":"2024-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.283502+00:00","generated_at":"2026-05-30T16:28:53.289559+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Neil Warma appointed President and CEO of ProMIS Neurosciences, effective August 1, 2024","bullets":["Base salary of $500,000 with annual discretionary bonus target of 50% of base salary.","Granted option to purchase 1,144,122 common shares (Initial Award) and 490,338 shares (Performance Award) at $1.15 per share.","Initial Award vests 25% on grant, remainder ratably over 36 months; Performance Award vests 25% when 10-day VWAP exceeds 3x exercise price, remainder over 36 months.","Severance: 12 months' salary plus pro-rated bonus and time-based option acceleration on non-CIC termination; 18 months' salary plus benefits on change-in-control termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-013244","json":"https://secwatch.observer/filing/0001558370-24-013244.json","markdown":"https://secwatch.observer/filing/0001558370-24-013244.md","text":"https://secwatch.observer/filing/0001558370-24-013244.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374339/000155837024013244/0001558370-24-013244-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374339/000155837024013244/pmn-20241008x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T16:28:53.289559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"622ae81f4b","claim":"Neil Warma was appointed as President and Chief Executive Officer at ProMIS Neurosciences Inc..","evidence_excerpt":"On October 8, 2024, ProMIS Neurosciences Inc. (the “Company”) appointed Neil Warma as the President and Chief Executive Officer (“CEO”) of the Company, effective August 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1374339/000155837024013244/0001558370-24-013244-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}